Valiant Evo International Clinical Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT02625324

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
  • Medtronic Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02625324
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Canada, Denmark, France, Italy, Netherlands, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02625324. Allocation not applicable; no masking; primary purpose treatment. Start 2016-04 (actual); primary completion 2017-12 (actual). Results posted on 2019-03-15.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Valiant Evo International Clinical Trial
Condition
Aortic Aneurysm, Thoracic
Intervention (Device)
Valiant Evo Thoracic Stent Graft System
Lead sponsor
Medtronic Cardiovascular (class: industry)

Record details

Record id
cardio:ct-nct02625324
Content hash
921c4d5645505a490943a56088406f2e1fb47f221b988cd04b85243dec3ac84c